First leukemia patient dosed with SMART101
Smart Immune has announced that the first adult leukemia patient has been dosed with SMART101, a T-cell progenitor cell injection.
France General Karine Rossignol Protcell At Memorial Sloankettering Cancer Center Smart Immune Memorial Sloankettering Cancer Center Protcellt Cell
Source: labiotech.eu